Pterygium
Pterygium is a common eye condition characterized by the growth of a non-cancerous, triangular-shaped tissue on the conjunctiva, which can extend onto the cornea. It typically develops due to prolonged exposure to UV radiation, dust, and other environmental irritants, and is more prevalent in individuals living in sunny climates. Symptoms may include redness, irritation, foreign body sensation, and blurred vision if the pterygium encroaches onto the cornea. Diagnosis of pterygium involves a comprehensive eye examination by an ophthalmologist, including slit-lamp biomicroscopy to visualize the growth and assess its extent. In some cases, additional imaging modalities such as anterior segment optical coherence tomography (AS-OCT) may be used to evaluate the involvement of the cornea and anterior segment structures.
The Retyne Infrared Eye Treatment Mask offers a promising adjunctive therapy for managing the symptoms of pterygium. By delivering targeted frequencies known for their anti-inflammatory and tissue-healing properties, the Retyne mask aids in reducing inflammation, promoting tissue repair, and alleviating symptoms associated with pterygium, such as redness and irritation. Additionally, the application of infrared light may help mitigate the progression of pterygium by reducing vascularization and fibrosis within the lesion. This innovative therapy provides a non-invasive and convenient option for individuals struggling with the discomfort and visual disturbances caused by pterygium, enhancing their overall treatment outcomes and ocular comfort.
The Retyne eye treatment mask utilizes a general selection of frequencies (0.07, 0.12, 0.6, 0.87, 2.25, 22.5, 187.5, 396.5, 587.5, 696.5) tailored to address Pterygium. These frequencies have been selected for their proven effectiveness in managing and treating this visual condition. Retyne's approach involves converting each frequency into invisible infrared light output, marking a groundbreaking fusion of frequencies with light—a pioneering technology pioneered by Retyne Labs. Inspired by the groundbreaking work of Dr. Rife, who identified healing properties in specific frequencies and utilized light for their transmission, Retyne's innovative method capitalizes on current research on invisible infrared technology and builds upon past studies on light transmission through frequency sources. The result is the Retyne eye Treatment Mask, a convergence of state-of-the-art advancements in the field of visual care.
Moreover, for those utilizing advanced hardware such as the RDPV4, a secondary set of specific frequencies for Pterygium; (2845: Pterygium [Eye Disorder]: 0.57, 0.68, 0.87, 2.5, 5.71, 32.5, 92.5, 322.54, 519.34, 653.69 ) is available. The RDPV4 machine offers an expanded range of frequencies, finely calibrated to provide even greater precision for the treatment of this Corneal Disorder. By incorporating this secondary set of frequencies, the RDPV4 elevates the potential therapeutic benefits of the Retyne eye Treatment Mask, catering to individuals seeking advanced solutions for their visual health needs.
The General set group exists at program 810: Corneal Disease: 0.07, 0.32, 0.95, 7.5, 84, 193.93, 237.5, 487.5, 706.21, 946.5
The Advanced Group 2845: Pterygium [Eye Disorder]: 0.57, 0.68, 0.87, 2.5, 5.71, 32.5, 92.5, 322.54, 519.34, 653.69
Compatibility
Standalone controller (Program #2) (Controller shipped with Retyne Eye Treatment Mask)
RDPV4 (Direct connect, use group 2845)
RDPV4 Light Mask Program button 2
Click here for instructions on using the Retyne Mask + Controller
